Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
NCT06485089 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-10-29
Summary
Evaluation of biomarkers for risk of developing breast cancer in women with obesity who are using tirzepatide to achieve weight loss.
Conditions
- Obesity
- Breast Cancer Risk
Interventions
- DRUG
-
Women taking tirzepatide as part of standard care in the Weight Managment Clinic
Sponsors & Collaborators
-
University of Kansas Medical Center
lead OTHER
Principal Investigators
-
Carol J Fabian, MD · University of Kansas Medical Center
Eligibility
- Min Age
- 40 Years
- Max Age
- 64 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-09-14
- Primary Completion
- 2026-02-28
- Completion
- 2026-04-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Laser Spectroscopy of Breast Tissue Through a Needle Device
NCT00918788 ·Status: COMPLETED
-
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831
NCT00898898 ·Status: COMPLETED
-
Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer
NCT00041353 ·Status: WITHDRAWN ·Phase: NA
-
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
NCT02028221 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
NCT01286233 ·Status: UNKNOWN
-
Impact of COX2 on Sera Biomarkers From Obese Subjects
NCT02062255 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Peptide Profiles of Women Undergoing Breast Biopsy
NCT00587821 ·Status: COMPLETED
-
RANKL Inhibition and Breast Tissue Biomarkers
NCT03629717 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
NCT01839045 ·Status: UNKNOWN
-
Comparison of Healthy Diets on Breast Cancer Markers
NCT02744079 ·Status: COMPLETED ·Phase: NA
-
Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants
NCT05054010 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
NCT06127979 ·Status: RECRUITING ·Phase: NA
-
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
NCT00255060 ·Status: COMPLETED
-
Markers for Breast Cancer
NCT00339248 ·Status: COMPLETED
-
Study of 68Ga-R10602
NCT06745804 ·Status: RECRUITING ·Phase: PHASE1
-
Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer
NCT01162200 ·Status: COMPLETED ·Phase: PHASE1
-
Intraoperative Radiotherapy for Early Stage Breast Cancer
NCT01189851 ·Status: COMPLETED ·Phase: NA
-
The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer
NCT01634984 ·Status: UNKNOWN
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Insulin Resistance and Breast Cancer
NCT00304941 ·Status: COMPLETED
-
Cyberknife for Early Stage Breast Cancer
NCT03946683 ·Status: COMPLETED ·Phase: NA
-
Effect of Weight Loss on Breast Density Using Digital Mammography and MRI in Women Who Are At Increased Risk For Breast Cancer
NCT01259076 ·Status: TERMINATED
-
Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation
NCT02958774 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Triple Negative Breast Cancer Biomarker Study
NCT01111175 ·Status: COMPLETED
-
Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer
NCT00291083 ·Status: COMPLETED